candesartan cilexetil






164 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1384488 Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 1992 Oct 15 2
2 1435062 Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats. Life Sci 1992 3
3 7500546 Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats. Jpn Circ J 1995 Sep 1
4 7533141 Regulation of neuronal nitric oxide synthase in rat adrenal medulla. Hypertension 1995 Mar 1
5 7621917 Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells. Eur J Pharmacol 1995 Apr 28 3
6 7714806 Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995 Apr 1
7 7768570 Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 1995 Jun 1
8 7788922 Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 1995 Jul 1 6
9 7810730 Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters. Am J Physiol 1994 Dec 3
10 7843746 Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 1995 Jan 9
11 7853793 Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 1994 Nov 6
12 7858853 AT1 receptor-mediated stimulation by angiotensin II of rat aortic fibronectin gene expression in vivo. Br J Pharmacol 1994 Nov 3
13 7867037 Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system. Cardiovasc Res 1994 Dec 3
14 7884578 TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation. J Hypertens Suppl 1994 Nov 1
15 7884581 Angiotensin II antagonists DuP 753 and TCV 116. J Hypertens Suppl 1994 Nov 2
16 7884582 Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function. J Hypertens Suppl 1994 Nov 1
17 7889191 Gene expression of the type-1 angiotensin II receptor in rat adrenal gland. Blood Press Suppl 1994 1
18 7889192 Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats. Blood Press Suppl 1994 2
19 7889195 Role of the renin-angiotensin system in hypertension in the elderly. Blood Press Suppl 1994 1
20 7889200 Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury. Blood Press Suppl 1994 2
21 7889201 Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats. Blood Press Suppl 1994 1
22 7889207 Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist. Blood Press Suppl 1994 4
23 7889210 Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats. Blood Press Suppl 1994 5
24 7889211 Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats. Blood Press Suppl 1994 1
25 8013547 Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone. Eur J Pharmacol 1994 Feb 21 1
26 8039844 Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994 Aug 1
27 8065233 Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats. Life Sci 1994 1
28 8138966 Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther 1994 Mar 2
29 8181146 Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994 May 4
30 8201847 TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Life Sci 1994 7
31 8205603 Effects of the angiotensin II receptor antagonist, TCV-116, on blood pressure and the renin-angiotensin system in healthy subjects. Clin Ther 1994 Jan-Feb 2
32 8221818 Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension. Clin Ther 1993 Jul-Aug 3
33 8301670 Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J Mol Cell Cardiol 1993 Nov 2
34 8505091 Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension 1993 Jun 1
35 8523451 Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 1995 Sep 1
36 8548907 Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 1996 Jan 15 1
37 8583480 Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. J Hum Hypertens 1995 Nov 1
38 8583793 Persistent inhibition of the pressor and aldosterone responses to angiotensin-II by TCV-116 in normotensive subjects. J Cardiovasc Pharmacol 1995 Sep 11
39 8603580 Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats. Endocrinology 1996 Mar 1
40 8674841 Effect of dietary chloride on aldosterone synthase induction and angiotensin II receptors in rat adrenals. Mol Cell Endocrinol 1995 Oct 30 2
41 8678895 CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells. Biochem Pharmacol 1996 Jul 12 1
42 8682082 Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments. Eur Heart J 1995 Dec 1
43 8717062 AT1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats. Clin Exp Pharmacol Physiol 1996 Apr 1
44 8738803 Angiotensin II and calcium blockers prevent glomerular phenotypic changes in remnant kidney model. J Am Soc Nephrol 1996 May 2
45 8743529 TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats. Kidney Int Suppl 1996 Jun 1
46 8986455 Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats. Hypertens Res 1996 Dec 2
47 9039142 Improvement in baroreflex function by an oral angiotensin receptor antagonist in rats with myocardial infarction. Hypertension 1997 Jan 1
48 9072428 Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery. Clin Exp Pharmacol Physiol Suppl 1995 Dec 2
49 9110382 Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Regul Pept 1997 Jan 29 2
50 9321751 Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy. J Hypertens 1997 Sep 2